Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structure supports the development of analogs for studying neurological pathways related to pain, depression, and epilepsy. Also explored in the design of selective receptor modulators due to its affinity for binding to neurotransmitter receptors. Shows potential in creating novel therapeutics with improved bioavailability and metabolic stability.